BioXcel Therapeutics (BTAI) Selling, General & Administrative (2017 - 2026)
BioXcel Therapeutics (BTAI) Selling, General & Administrative (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | 317.00 Mn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | -1.80 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 206.70 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 1.13 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 439.70 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 449.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | BioXcel Therapeutics | 24.93 Mn | 24.93 Mn | 160,000.00 | 7.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.19 Mn |
| Mar 31, 2026 | 7.19 Mn |
| Dec 31, 2025 | 3.81 Mn |
| Sep 30, 2025 | 5.38 Mn |
| Jun 30, 2025 | 5.61 Mn |
| Mar 31, 2025 | 5.70 Mn |
| Dec 31, 2024 | 4.09 Mn |
| Sep 30, 2024 | 7.68 Mn |
| Jun 30, 2024 | 9.45 Mn |
| Mar 31, 2024 | 13.26 Mn |
| Dec 31, 2023 | 9.60 Mn |
| Sep 30, 2023 | 24.34 Mn |
| Jun 30, 2023 | 25.87 Mn |
| Mar 31, 2023 | 23.60 Mn |
| Dec 31, 2022 | 20.66 Mn |
| Sep 30, 2022 | 17.05 Mn |
| Jun 30, 2022 | 18.38 Mn |
| Mar 31, 2022 | 12.92 Mn |
| Dec 31, 2021 | 13.61 Mn |
| Sep 30, 2021 | 14.88 Mn |